SCHEMBL30179192

SCHEMBL30179192

CCOC(=O)N1CCCN(C2CCC3(CC2)C(=O)Nc2ccc(C)cc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.48
ALOX12 P18054 1/20 0.48
MAPK1 P28482 2/20 0.44
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.41
KMT2A Q03164 3/20 0.40
HRH3 Q9Y5N1 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
TP53 P04637 1/20 0.39
MEN1 O00255 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20066049 1.00 SMN1; SMN2 (0.48) SMN1; SMN2GAAALOX12MAPK1ALDH1A1
SCHEMBL30179202 0.93 SMN1; SMN2 (0.49) SMN1; SMN2GAAALOX12MAPK1ALDH1A1
SCHEMBL20066048 0.93 SMN1; SMN2 (0.49) SMN1; SMN2GAAALOX12MAPK1ALDH1A1
SCHEMBL20066050 0.91 ALDH1A1 (0.45) SMN1; SMN2GAAALOX12MAPK1ALDH1A1
SCHEMBL30179220 0.91 ALDH1A1 (0.45) SMN1; SMN2GAAALOX12MAPK1ALDH1A1
SCHEMBL20066053 0.90 ALDH1A1 (0.47) SMN1; SMN2GAAALOX12MAPK1ALDH1A1
SCHEMBL30179229 0.90 ALDH1A1 (0.47) SMN1; SMN2GAAALOX12MAPK1ALDH1A1
SCHEMBL30179395 0.89 OPRM1 (0.46) SMN1; SMN2GAAALOX12MAPK1KMT2A
SCHEMBL20066046 0.89 OPRM1 (0.46) SMN1; SMN2GAAALOX12MAPK1KMT2A
SCHEMBL30179324 0.88 IP6K1 (0.43) MAPK1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109996792-B Heterocyclic compounds having activity as modulators of muscarinic M1 and/or M4 receptors in the treatment of CNS diseases and pain 赫普泰雅治疗有限公司 2023-02-17 CN disclosed